ACTO Earns Gold at Brandon Hall Technology Awards 2021

Toronto, Ontario (December 15, 2021) –  ACTO, the creator of the innovative Omnichannel Education Platform for Life Sciences, today announced it won a coveted Brandon Hall Group Gold award for excellence in Best Advance in Learning Management Measurement/Business Impact Tools. The award is for Digitally Transforming the Life Sciences Industry with Omnichannel Education. ACTO’s technology uses AI-powered mobile experiences to …

eyeforpharma Awards Recognize Two ACTO Use Cases as Finalists

TORONTO, Nov. 25, 2019 /CNW/ – Two of ACTO’s use cases have been nominated as finalists in the eyeforpharma Awards, which focus on recognizing genuine, truly innovative and meaningful approaches to excellence in the pharmaceutical industry. AstraZeneca has been nominated in the ‘Most Promising MVP/Pilot’ category for its ACTO use case. ACTO has been nominated in the ‘Most Valuable Data & Insights …

ACTO and Teleflex Collaboration Leads to Improved Sales Performance and Wins Bronze in the 2019 Brandon Hall Group Human Capital Management Excellence Awards for Learning Technology Implementation

TORONTO, Sept. 17, 2019 /CNW/ – ACTO and Teleflex’s Vascular Division won a coveted Brandon Hall Group Bronze award for excellence in the “Best Advance in Learning Technology Implementation” category for their groundbreaking efforts to improve sales performance. The ACTO and Teleflex case study demonstrates the commercial success that life sciences companies can achieve after implementing new technology to gather field data and …

ACTO Wins Gold Stevie® Award in the Cloud Platform Category in 2019 International Business Awards

TORONTO, Aug. 22, 2019 /CNW/ – ACTO was named the winner of a Gold Stevie® Award in the Cloud Platform category in The 16th Annual International Business Awards®. The International Business Awards are the world’s premier business awards program. All individuals and organizations worldwide – public and private, for-profit and non-profit, large and small – are eligible to submit nominations. The 2019 IBAs received …

ACTO Kicks Off 2021 with Chart-Topping Growth

Life sciences tech leader triples headcount, announces 5X ARR boost TORONTO, Jan. 28, 2021 /PRNewswire/ – ACTO, the Omnichannel Education Platform for Life Sciences, today announced major growth across a range of key metrics during 2020, including a 500% increase in annual recurring revenue since 2018. During the global pandemic, ACTO has cemented its position as an essential partner for life sciences …

About

We’re committed to Life SciencesOur goal is to help improve the human condition and make a positive impact on people’s lives by supporting the work of the Life Sciences industry.We’re committed to Life SciencesOur goal is to help improve the human condition and make a positive impact on people’s lives by supporting the work of the Life Sciences industry.Our missionOur …

ACTO Achieves 158% Year to Date Revenue Growth in 2019 and Has Digitally Transformed Over 50 Life Sciences Companies

TORONTO, Dec. 5, 2019 /CNW/ – ACTO achieved 158% year to date revenue growth and has digitally transformed over 50 life sciences companies, including global pharma, medical device, and dental companies. Since its launch one year ago, the ACTO Commercialization Cloud for Life Sciences has digitally transformed companies such as AstraZeneca, Teleflex, and Philips Respironics, enabling their field force to promote on …

ACTO Named One of the 2019 PM360 ELITE 100

TORONTO, May 21, 2019 /CNW/ – PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors, has named Parth Khanna, Kapil Kalra, and Kumar Erramilli as one of the 2019 PM360 ELITE 100 in the Entrepreneurs category. Now in its fifth year, the PM360 ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) represent the most influential people in the healthcare industry today. …

ACTO Emerges as a Leader in Life Sciences Commercialization; Closes Strong Calendar Year 2018 with 184% Revenue Growth and Doubled Customer Base

TORONTO, Jan. 31, 2019 /CNW/ – ACTO Technologies Inc. emerged as a leader in life sciences commercialization by closing a strong calendar year 2018 with 184% revenue growth and a doubled customer base. This past year, ACTO secured global, innovative pharmaceutical, medical device, and dental companies like Kala Pharmaceuticals, Teleflex, and Kulzer Dental US as clients. “At ACTO, we are on a …